Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today
Loading...
Lupin receives 5 observations from USFDA for Vizag facility

The USFDA inspection for the API facility at Vizag was carried out between January 13, 2020 and January 17, 2020, and it closed five 483 observations

 
 
Wockhardt latest medicines: Wockhardt announces two new drugs for skin infections, its shares rise by 14 per cent intraday. Here's what this means
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive
Nutraceuticals, which consist of vitamins and minerals, protein supplements, energy drinks and growth supplements, have clocked higher growth than prescription drugs
Industry watchers, however, say that it may lead to some pharma players opting more for medicines not falling under the drug price control regime
 
 
For the month of December, the Indian pharmaceutical market growth stood at 8.8 per cent y-o-y compared to 9.3 per cent in December 2018
Sun Pharma's issues with Halol was started in 2015, as the FDA issued a 'warning letter' subsequent to an inspection in September 2014
Arjun Deshpande's unique pharmacy chain Generic Aadhar sells generic medicines to the masses at much cheaper rates than the market price
Advertisement